Recent developments in GLP-1 receptor agonist are centered on advanced administration methods, particularly the emergence of rapidly disintegrating pills. These advanced forms intend to improve individual ease of use and potentially present faster action, leading to enhanced clinical results. Experts believe that this platform holds significant opp